ChartRow logo
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)Stock · Health Care
$50.22-1.65%
as of market close, Sep 18, 2026
☾ AH
PeersMRNALLYUNHJNJMRKTMO

GSK — GSK plc American Depositary Shares (Each representing two Ordinary Shares) price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in GSK be worth today? →
GSK returns: By year · By month · By week · Trailing

Key stats

Price data

Price
$50.22
Change YTD
+2.41%
Next earnings
Nov 4, 2026
Market cap
103.4B
Enterprise value
122.7B
Shares outstanding
2.1B
52W low
$39.29
52W high
$61.70
From 52W high
-18.61%
From 52W low
+27.82%
52W range
49%
Beta
0.38

Volume

Rel volume
1.61×
30D volume
2.9M
30D $ vol
147.6M

Fundamentals

Sales (ttm)
43.1B
Sales/share
$20.95
EPS (ttm)
$3.66
FCF (ttm)
10.2B
FCF/share
$4.96
Book value/share
$10.71
Net margin
19.25%
ROE
37.65%
ROA
10.09%
Debt / equity
0.90×
Current ratio
0.82

Growth (CAGR, ttm) · 10Y

Sales
+7.57%+6.06%+6.66%+1.66%
Net income
+120.30%-24.45%+0.26%-4.24%
Shares
-0.60%+0.27%+0.43%-1.70%

Per-share growth (CAGR, ttm) · 10Y

EPS
+130.68%-25.95%+0.03%-3.56%
Sales/share
+8.23%+5.77%+6.21%+3.42%
Book value/share
+29.03%+19.62%+1.85%+7.12%
Dividend/share
+11.79%+4.89%-7.45%-3.33%
Price
+24.63%+10.37%+5.22%+1.59%
Total return
+29.05%+14.75%+9.56%+6.45%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
13.7×
P/OI (ttm)
9.9×
Fwd P/E
10.1×
P/S (ttm)
2.4×
P/B (mrq)
4.7×
P/FCF (ttm)
10.1×
EV/EBITDA (fy)
9.1×
EV/Sales (ttm)
2.8×
FCF yield (ttm)
9.89%
Dividend yield (fwd)
3.47%
Dividend/share (fwd)
$1.74
Buyback yield (cash, ttm)
1.74%
Shareholder yield (cash, ttm)
5.01%

Vs own 10Y history

P/E
35th
P/OI
21st
P/S
47th
P/B
32nd

Bar = where today’s multiple sits in GSK’s own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return · as of 2026-09-18

1D
-1.65%
5D
+4.34%
1M
-1.82%
3M
-0.89%
YTD
+2.41%
1Y
+24.62%
5Y
+29.00%

Financial statements

Open full GSK financials →
Loading financial statements…
TickerName1M1D
NVSNovartis AG-9.18%-0.39%
NVONovo Nordisk A/S-5.40%+0.12%
SNYSanofi ADS-5.54%-1.53%
ARGXargenx SE American Depositary Shares-0.27%-0.55%
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)+4.76%-0.73%
NTRANatera Inc.+18.51%+0.84%
TEVATeva Pharmaceutical Industries Limited American Depositary Shares+6.56%-0.54%
RVMDRevolution Medicines Inc.-11.60%-3.04%

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) trades at $50.22 with a live price and an interactive chart covering 46+ years of daily price history, plus key valuation metrics. ChartRow also publishes GSK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GSK financial statements →